BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Joanna L Richens, Richard A Urbanowicz, Elizabeth AM Lunt, Rebecca Metcalf, Jonathan Corne, Lucy Fairclough, Paul O'Shea. Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary diseaseRespiratory Research 2009; 10(1) doi: 10.1186/1465-9921-10-29
2
Jiang Chen Peng, Jun Shen, Zhi Hua Ran. Novel agents in the future: Therapy beyond anti-TNF agents in inflammatory bowel diseaseJournal of Digestive Diseases 2014; 15(11): 585 doi: 10.1111/1751-2980.12193
3
Claire Painchart, Séverine Brabant, Nicolas Duveau, Maria Nachury, Pierre Desreumaux, Julien Branche, Romain Gérard, Clémentine Lauriot Dit Prevost, Pauline Wils, Thomas Lambin, Médina Boualit, Myriam Labalette, Benjamin Pariente. Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn’s DiseaseDigestive Diseases and Sciences 2020; 65(5): 1445 doi: 10.1007/s10620-019-05865-3
4
Toshimi Chiba, Mikiya Endo, Shoko Matsushita, Mika Sasaki, Shoichi Chida, Yosuke Toya, Satoshi Kasugai, Nozomi Matsuda, Shunsuke Orikasa, Yukito Abiko, Norihiko Kudara, Shuhei Oana, Masaki Endo, Kazuyuki Suzuki. Peripheral Blood CD64 Levels Decrease in Crohn’s Disease following Granulocyte and Monocyte Adsorptive ApheresisCase Reports in Gastroenterology 2011; 5(3): 667 doi: 10.1159/000335316
5
Le-Ning Xue, Ke-Qun Xu, Wei Zhang, Qiang Wang, Jia Wu, Xiao-Yong Wang. Associations Between Vitamin D Receptor Polymorphisms and Susceptibility to Ulcerative Colitis and Crohnʼs DiseaseInflammatory Bowel Diseases 2013; 19(1): 54 doi: 10.1002/ibd.22966
6
Sarah C Davies, Tran M Nguyen, Claire E Parker, John K MacDonald, Vipul Jairath, Reena Khanna. Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's diseaseCochrane Database of Systematic Reviews 2019;  doi: 10.1002/14651858.CD012804.pub2
7
Maria Lia Scribano, Laura Cantoro, Marzia Marrollo, Rocco Cosintino, Anna Kohn. Mucosal Healing With Thalidomide in Refractory Crohn’s Disease Patients Intolerant of Anti-TNF-α DrugsJournal of Clinical Gastroenterology 2014; 48(6): 530 doi: 10.1097/MCG.0000000000000122
8
Bram Verstockt, Clémentine Perrier, Gert De Hertogh, Jonathan Cremer, Brecht Creyns, Gert Van Assche, Marc Ferrante, Jan L. Ceuppens, Séverine Vermeire, Christine Breynaert. Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel DiseaseFrontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02983
9
Andrés Sansó Sureda, Vicenç Rocamora Durán, Amparo Sapiña Camaró, Vanesa Royo Escosa, María José Bosque López. Ustekinumab en paciente con enfermedad de Crohn y psoriasis inducida por anti-TNF-αGastroenterología y Hepatología 2011; 34(8): 546 doi: 10.1016/j.gastrohep.2011.04.003
10
Ka Yee Fung, Paul M. Nguyen, Tracy L. Putoczki. Tumor MicroenvironmentAdvances in Experimental Medicine and Biology 2020; 1240: 59 doi: 10.1007/978-3-030-38315-2_5
11
Sanjay Mukherjee, Evagelia C. Laiakis, Albert J. Fornace, Sally A. Amundson. Impact of inflammatory signaling on radiation biodosimetry: mouse model of inflammatory bowel diseaseBMC Genomics 2019; 20(1) doi: 10.1186/s12864-019-5689-y
12
Marianna Roselli, Alberto Finamore, Silvia Nuccitelli, Paola Carnevali, Patrizia Brigidi, Beatrice Vitali, Fabio Nobili, Rita Rami, Ivana Garaguso, Elena Mengheri. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of γδT and regulatory T cells of intestinal intraepithelial lymphocytesInflammatory Bowel Diseases 2009; 15(10): 1526 doi: 10.1002/ibd.20961
13
Anja Schulz-Kuhnt, Stefan Wirtz, Markus F. Neurath, Imke Atreya. Regulation of Human Innate Lymphoid Cells in the Context of Mucosal InflammationFrontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01062
14
David Schwartz. Anti-IL-12/23Inflammatory Bowel Diseases 2009; 15(12): 1927 doi: 10.1002/ibd.20990
15
Jun Gu, Gang Liu, Junjie Xing, Haihan Song, Zhongchuan Wang. Fecal bacteria from Crohn's disease patients more potently activated NOD-like receptors and Toll-like receptors in macrophages, in an IL-4-repressible fashionMicrobial Pathogenesis 2018; 121: 40 doi: 10.1016/j.micpath.2018.05.009
16
Jeanne Tung, William J. Sandborn. Pediatric Inflammatory Bowel Disease2008; : 403 doi: 10.1007/978-0-387-73481-1_32
17
Maho Ikeda, Fuminao Takeshima, Hajime Isomoto, Saburo Shikuwa, Yohei Mizuta, Yoshiyuki Ozono, Shigeru Kohno. Simvastatin Attenuates Trinitrobenzene Sulfonic Acid-Induced Colitis, but Not Oxazalone-Induced ColitisDigestive Diseases and Sciences 2008; 53(7): 1869 doi: 10.1007/s10620-007-0102-0
18
Caitriona Ryan, Breck Thrash, Richard B Warren, Alan Menter. The use of ustekinumab in autoimmune diseaseExpert Opinion on Biological Therapy 2010; 10(4): 587 doi: 10.1517/14712591003724670
19
Sam Khorrami, Daniel Ginard, Ignacio Marín-Jiménez, María Chaparro, Mónica Sierra, Mariam Aguas, Beatriz Sicilia, Valle García-Sánchez, Cristina Suarez, Albert Villoria, Carlos Taxonera, Antonio Velasco-Guardado, Javier Martínez-González, Javier P. Gisbert. Ustekinumab for the Treatment of Refractory Crohnʼs DiseaseInflammatory Bowel Diseases 2016; 22(7): 1662 doi: 10.1097/MIB.0000000000000842
20
Bi-Feng Qian, Susan L. Tonkonogy, Balfour R. Sartor. Reduced responsiveness of HLA-B27 transgenic rat cells to TGF-β and IL-10-mediated regulation of IFN-γ productionInflammatory Bowel Diseases 2008; 14(7): 921 doi: 10.1002/ibd.20415
21
John K MacDonald, Tran M Nguyen, Reena Khanna, Antje Timmer. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's diseaseCochrane Database of Systematic Reviews 2016;  doi: 10.1002/14651858.CD007572.pub3
22
Michael Elliott, Jacqueline Benson, Marion Blank, Carrie Brodmerkel, Daniel Baker, Kristin Ruley Sharples, Philippe Szapary. Ustekinumab: Lessons Learned from Targeting Interleukin-12/23p40 in Immune-Mediated DiseasesAnnals of the New York Academy of Sciences 2009; 1182(1): 97 doi: 10.1111/j.1749-6632.2009.05070.x
23
Holger Schäffler, Dogan Doruk Demircioglu, Daniel Kühner, Sarah Menz, Annika Bender, Ingo B. Autenrieth, Peggy Bodammer, Georg Lamprecht, Friedrich Götz, Julia-Stefanie Frick, A. J. Bäumler. NOD2 Stimulation by Staphylococcus aureus-Derived Peptidoglycan Is Boosted by Toll-Like Receptor 2 Costimulation with Lipoproteins in Dendritic CellsInfection and Immunity 2014; 82(11): 4681 doi: 10.1128/IAI.02043-14
24
M. Čitar, B. Hacin, G. Tompa, M. Štempelj, I. Rogelj, J. Dolinšek, M. Narat, B. Bogovič Matijašić. Human intestinal mucosa-associated Lactobacillus and Bifidobacterium strains with probiotic properties modulate IL-10, IL-6 and IL-12 gene expression in THP-1 cellsBeneficial Microbes 2015; 6(3): 325 doi: 10.3920/BM2014.0081
25
Santhosh Kumar, Brant R. Ward, Anne-Marie Irani. Future Prospects of Biologic Therapies for Immunologic DiseasesImmunology and Allergy Clinics of North America 2017; 37(2): 431 doi: 10.1016/j.iac.2017.01.013
26
Javier P. Gisbert, María Chaparro. Ustekinumab to treat Crohn's diseaseGastroenterología y Hepatología (English Edition) 2017; 40(10): 688 doi: 10.1016/j.gastre.2017.08.003
27
Qing-Feng Tang, Qing Ji, Yu Tang, Song-Jiao Hu, Yi-Jie Bao, Wen Peng, Pei-Hao Yin. Golgi Phosphoprotein 2 Down-regulates the Th1 Response in Human Gastric Cancer Cells by Suppressing IL-12AAsian Pacific Journal of Cancer Prevention 2013; 14(10): 5747 doi: 10.7314/APJCP.2013.14.10.5747
28
Benno Weigmann. T-Helper CellsMethods in Molecular Biology 2014; 1193: 143 doi: 10.1007/978-1-4939-1212-4_14
29
Nair Campos, Fernando Magro, Ana Rita Castro, Joana Cabral, Pedro Rodrigues, Ricardo Silva, Rui Appelberg, Susana Rodrigues, Susana Lopes, Guilherme Macedo, Amélia Sarmento. Macrophages from IBD patients exhibit defective tumour necrosis factor-α secretion but otherwise normal or augmented pro-inflammatory responses to infectionImmunobiology 2011; 216(8): 961 doi: 10.1016/j.imbio.2011.01.002
30
Rebecca Faleiro, Ji Liu, Deshapriya Karunarathne, Aleksandra Edmundson, Clay Winterford, Tam Hong Nguyen, Lisa A Simms, Graham Radford‐Smith, Michelle Wykes. Crohn's disease is facilitated by a disturbance of programmed death‐1 ligand 2 on blood dendritic cellsClinical & Translational Immunology 2019; 8(7) doi: 10.1002/cti2.1071
31
Murat KEKİLLİ, Alpaslan TANOĞLU, Fatih KARAAHMET, Zeynal DOĞAN, Murat CAN, Abdurrahim SAYILIR, Başak ÇAKAL, Tolga DÜZENLİ, Yavuz BEYAZIT. Midkine level may be used as a noninvasive biomarker in Crohn’s diseaseTURKISH JOURNAL OF MEDICAL SCIENCES 2020; 44(2): 324 doi: 10.3906/sag-1904-167
32
Reena Khanna, Brian G Feagan. Ustekinumab for the treatment of Crohn’s diseaseImmunotherapy 2013; 5(8): 803 doi: 10.2217/imt.13.81
33
William J. Sandborn, Brian G. Feagan, Richard N. Fedorak, Ellen Scherl, Mark R. Fleisher, Seymour Katz, Jewel Johanns, Marion Blank, Paul Rutgeerts. A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's DiseaseGastroenterology 2008; 135(4): 1130 doi: 10.1053/j.gastro.2008.07.014
34
Javier P. Gisbert, María Chaparro. Ustekinumab en el tratamiento de la enfermedad de CrohnGastroenterología y Hepatología 2017; 40(10): 688 doi: 10.1016/j.gastrohep.2017.08.006
35
Laszlo Bene, Andras Falus, Noemi Baffy, Andras Kristof Fulop. Cellular and Molecular Mechanisms in the Two Major Forms of Inflammatory Bowel DiseasePathology & Oncology Research 2011; 17(3): 463 doi: 10.1007/s12253-011-9397-4
36
Reena Khanna, Jan C Preiss, John K MacDonald, Antje Timmer, Antje Timmer. Cochrane Database of Systematic Reviews2015;  doi: 10.1002/14651858.CD007572.pub2
37
Jian Li, Andria L. Doty, Atif Iqbal, Sarah C. Glover. The differential frequency of Lineage−CRTH2−CD45+NKp44−CD117−CD127+ILC subset in the inflamed terminal ileum of patients with Crohn’s diseaseCellular Immunology 2016; : 63 doi: 10.1016/j.cellimm.2016.05.001
38
BL Kelsall. Innate and adaptive mechanisms to control of pathological intestinal inflammationThe Journal of Pathology 2008; 214(2): 242 doi: 10.1002/path.2286
39
Karine Mariane Steigleder, Fernando Lopes Ponte Neto, Cristiane Kibune Nagasako, Raquel Franco Leal. Biological Therapy for Inflammatory Bowel Disease2020;  doi: 10.5772/intechopen.90536
40
Zhenggang Jiang, Wei Xu, Kang Li, Yan Yue, Lin Xu, Fei Ye, Sidong Xiong. Remission of CVB3-induced viral myocarditis byin vivoTh2 polarization via hydrodynamics-based interleukin-4 gene transferThe Journal of Gene Medicine 2008; 10(8): 918 doi: 10.1002/jgm.1215
41
Kan Shida, Junko Kiyoshima-Shibata, Rumi Kaji, Masato Nagaoka, Masanobu Nanno. Peptidoglycan from lactobacilli inhibits interleukin-12 production by macrophages induced byLactobacillus caseithrough Toll-like receptor 2-dependent and independent mechanismsImmunology 2009; 128(1pt2): e858 doi: 10.1111/j.1365-2567.2009.03095.x
42
Omri Wolk, Svetlana Epstein, Viktoriya Ioffe-Dahan, Shimon Ben-Shabat, Arik Dahan. New targeting strategies in drug therapy of inflammatory bowel disease: mechanistic approaches and opportunitiesExpert Opinion on Drug Delivery 2013; 10(9): 1275 doi: 10.1517/17425247.2013.800480
43
Yoshihiro Hirata, Sozaburo Ihara, Kazuhiko Koike. Targeting the complex interactions between microbiota, host epithelial and immune cells in inflammatory bowel diseasePharmacological Research 2016; 113: 574 doi: 10.1016/j.phrs.2016.09.044
44
N. Maharshak, G. Hart, E. Ron, E. Zelman, A. Sagiv, N. Arber, E. Brazowski, R. Margalit, E. Elinav, I. Shachar. CCL2 (pM levels) as a therapeutic agent in inflammatory bowel disease models in miceInflammatory Bowel Diseases 2010; 16(9): 1496 doi: 10.1002/ibd.21254
45
Farzana Rashid, Gary R. Lichtenstein. Pediatric Inflammatory Bowel Disease2017; : 425 doi: 10.1007/978-3-319-49215-5_35
46
Tao Liu, Shao-Heng He, Peng-Yuan Zheng, Tao-Yuan Zhang, Bin-Quan Wang, Ping-Chang Yang. Staphylococcal enterotoxin B increases TIM4 expression in human dendritic cells that drives naïve CD4 T cells to differentiate into Th2 cellsMolecular Immunology 2007; 44(14): 3580 doi: 10.1016/j.molimm.2007.03.004
47
Clémentine Perrier, Paul Rutgeerts. Cytokine blockade in inflammatory bowel diseasesImmunotherapy 2011; 3(11): 1341 doi: 10.2217/imt.11.122
48
C. Ma, R. N. Fedorak, G. G. Kaplan, L. A. Dieleman, S. M. Devlin, N. Stern, K. I. Kroeker, C. H. Seow, Y. Leung, K. L. Novak, B. P. Halloran, V. W. Huang, K. Wong, P. K. Blustein, S. Ghosh, R. Panaccione. Clinical, endoscopic and radiographic outcomes with ustekinumab in medically-refractory Crohn's disease: real world experience from a multicentre cohortAlimentary Pharmacology & Therapeutics 2017; 45(9): 1232 doi: 10.1111/apt.14016
49
Nina Holland, Jing Dong, Elizabeth Garnett, Nishat Shaikh, Karen Huen, Paul Harmatz, Anthony Olive, Harland S Winter, Benjamin D Gold, Stanley A Cohen, Robert N Baldassano, Barbara S Kirschner, Melvin B Heyman. Reduced Intracellular T-Helper 1 Interferon-Gamma in Blood of Newly Diagnosed Children With Crohn's Disease and Age-Related Changes in Th1/Th2 Cytokine ProfilesPediatric Research 2008; 63(3): 257 doi: 10.1203/PDR.0b013e318163a897
50
Claudia Pena Rossi, Stephen B Hanauer, Ratko Tomasevic, John O Hunter, Ira Shafran, Hans Graffner. Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding studyBMC Gastroenterology 2009; 9(1) doi: 10.1186/1471-230X-9-22
51
Parthasarathy Chandrakesan, Ishfaq Ahmed, Anisha Chinthalapally, Pomila Singh, Shanjana Awasthi, Shrikant Anant, Shahid Umar, S. M. Payne. Distinct Compartmentalization of NF-κB Activity in Crypt and Crypt-Denuded Lamina Propria Precedes and Accompanies Hyperplasia and/or Colitis following Bacterial InfectionInfection and Immunity 2012; 80(2): 753 doi: 10.1128/IAI.06101-11
52
John H. Chidlow, Deepti Shukla, Matthew B. Grisham, Christopher G. Kevil. Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenuesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2007; 293(1): G5 doi: 10.1152/ajpgi.00107.2007
53
P. Mansueto, G. Iacono, A. Seidita, A. D'Alcamo, D. Sprini, A. Carroccio. Review article: intestinal lymphoid nodular hyperplasia in children - the relationship to food hypersensitivityAlimentary Pharmacology & Therapeutics 2012; : n/a doi: 10.1111/j.1365-2036.2012.05062.x
54
Thanh-Huyen Tran, Mansoor M Amiji. Targeted delivery systems for biological therapies of inflammatory diseasesExpert Opinion on Drug Delivery 2015; 12(3): 393 doi: 10.1517/17425247.2015.972931
55
Fei Ma, Mingning Zhao, Zhenyu Song, Zhongchuan Wang. T‐bet interferes with PD‐1/PD‐L1‐mediated suppression of CD4 + T cell inflammation and survival in Crohn's disease Clinical and Experimental Pharmacology and Physiology 2019; 46(9): 798 doi: 10.1111/1440-1681.13127
56
Christopher J. Lessard, Indra Adrianto, John A. Ice, Graham B. Wiley, Jennifer A. Kelly, Stuart B. Glenn, Adam J. Adler, He Li, Astrid Rasmussen, Adrienne H. Williams, Julie Ziegler, Mary E. Comeau, Miranda Marion, Benjamin E. Wakeland, Chaoying Liang, Paula S. Ramos, Kiely M. Grundahl, Caroline J. Gallant, Graciela S. Alarcón, Juan-Manuel Anaya, Sang-Cheol Bae, Susan A. Boackle, Elizabeth E. Brown, Deh-Ming Chang, Soo-Kyung Cho, Lindsey A. Criswell, Jeffrey C. Edberg, Barry I. Freedman, Gary S. Gilkeson, Chaim O. Jacob, Judith A. James, Diane L. Kamen, Robert P. Kimberly, Jae-Hoon Kim, Javier Martin, Joan T. Merrill, Timothy B. Niewold, So-Yeon Park, Michelle A. Petri, Bernardo A. Pons-Estel, Rosalind Ramsey-Goldman, John D. Reveille, R. Hal Scofield, Yeong Wook Song, Anne M. Stevens, Betty P. Tsao, Luis M. Vila, Timothy J. Vyse, Chack-Yung Yu, Joel M. Guthridge, Kenneth M. Kaufman, John B. Harley, Edward K. Wakeland, Carl D. Langefeld, Patrick M. Gaffney, Courtney G. Montgomery, Kathy L. Moser. Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as Susceptibility Loci for Systemic Lupus Erythematosus in a Large-Scale Multiracial Replication StudyThe American Journal of Human Genetics 2012; 90(4): 648 doi: 10.1016/j.ajhg.2012.02.023
57
Shining Ma, Tao Jiang, Rui Jiang. Constructing tissue-specific transcriptional regulatory networks via a Markov random fieldBMC Genomics 2018; 19(S10) doi: 10.1186/s12864-018-5277-6
58
Bruce E. Sands, Eric W. Jacobson, Thomas Sylwestrowicz, Ziad Younes, Gerald Dryden, Richard Fedorak, Susan Greenbloom. Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohnʼs diseaseInflammatory Bowel Diseases 2010; 16(7): 1209 doi: 10.1002/ibd.21159
59
M. V. Shapina, B. A. Nanaeva, A. V. Vardanyan. EFFICACY AND SAFETY OF USTEKINUMAB FOR CROHN’S DISEASE (reviewKoloproktologia 2019; 18(3(69)): 119 doi: 10.33878/2073-7556-2019-18-3-119-130
60
Wojciech Blonski, Faten Aberra, Gary R. Lichtenstein. Pediatric Inflammatory Bowel Disease2013; : 357 doi: 10.1007/978-1-4614-5061-0_34
61
Silvio Danese, Stefanos Bonovas, Laurent Peyrin-Biroulet. Positioning Ustekinumab in Crohn’s Disease: From Clinical Evidence to Clinical PracticeJournal of Crohn's and Colitis 2017; 11(10): 1258 doi: 10.1093/ecco-jcc/jjx079
62
Guntram A. Grassl, Yanet Valdez, Kirk S.B. Bergstrom, Bruce A. Vallance, B. Brett Finlay. Chronic Enteric Salmonella Infection in Mice Leads to Severe and Persistent Intestinal FibrosisGastroenterology 2008; 134(3): 768 doi: 10.1053/j.gastro.2007.12.043
63
Serban Gologan, Razvan Iacob, Daniela Iancu, Speranta Iacob, Bogdan Cotruta, Roxana Vadan, Ana-Maria Catuneanu, Ileana Constantinescu, Ligia Barbarii, Cristian Gheorghe, Mircea Diculescu. Inflammatory gene expression profiles in Crohn's disease and ulcerative colitis: A comparative analysis using a reverse transcriptase multiplex ligation-dependent probe amplification protocolJournal of Crohn's and Colitis 2013; 7(8): 622 doi: 10.1016/j.crohns.2012.08.015
64
Mark Löwenberg, Geert D’Haens. Novel Targets for Inflammatory Bowel Disease TherapeuticsCurrent Gastroenterology Reports 2013; 15(2) doi: 10.1007/s11894-012-0311-3
65
Qingdong Guan, Jiguo Zhang. Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel DiseaseMediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/4810258
66
Ebrahim Eskandari-Nasab, Adel Sepanjnia, Mehdi Moghadampour, Mehdi Hadadi-fishani, Alireza Rezaeifar, Abolghasem Asadi-Saghandi, Behrooz Sadeghi-Kalani, Mahdi Dehghan Manshadi, Fatemeh Pourrajab, Hossein Pourmasoumi. Circulating levels of interleukin (IL)-12 and IL-13 in Helicobacter pylori-infected patients, and their associations with bacterial CagA and VacA virulence factorsScandinavian Journal of Infectious Diseases 2013; 45(5): 342 doi: 10.3109/00365548.2012.737930
67
Aiping Bai, Zhikang Peng. Biological therapies of inflammatory bowel diseaseImmunotherapy 2010; 2(5): 727 doi: 10.2217/imt.10.51
68
Tiffanny N Newman, Elisabetta Liverani, Elitza Ivanova, Gian L Russo, Nick Carpino, Doina Ganea, Fayez Safadi, Satya P Kunapuli, Alexander Y Tsygankov. Members of the novel UBASH3/STS/TULA family of cellular regulators suppress T‐cell‐driven inflammatory responses in vivo Immunology & Cell Biology 2014; 92(10): 837 doi: 10.1038/icb.2014.60
69
Reena Khanna, Brian G Feagan. Safety of infliximab for the treatment of inflammatory bowel disease: current understanding of the potential for serious adverse eventsExpert Opinion on Drug Safety 2015; 14(6): 987 doi: 10.1517/14740338.2015.1029915
70
Špela Konjar, Cristina Ferreira, Birte Blankenhaus, Marc Veldhoen. Intestinal Barrier Interactions with Specialized CD8 T CellsFrontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.01281
71
Nadeem O. Kaakoush, Nandan P. Deshpande, Marc R. Wilkins, Chew Gee Tan, Jose A. Burgos-Portugal, Mark J. Raftery, Andrew S. Day, Daniel A. Lemberg, Hazel Mitchell, Dipshikha Chakravortty. The Pathogenic Potential of Campylobacter concisus Strains Associated with Chronic Intestinal DiseasesPLoS ONE 2011; 6(12): e29045 doi: 10.1371/journal.pone.0029045
72
Claudia Guzy, Anja Schirbel, Daniela Paclik, Bertram Wiedenmann, Axel Dignass, Andreas Sturm. Enteral and parenteral nutrition distinctively modulate intestinal permeability and T cell function in vitroEuropean Journal of Nutrition 2009; 48(1): 12 doi: 10.1007/s00394-008-0754-3
73
Reena Khanna, Nilesh Chande, Séverine Vermeire, William J. Sandborn, Claire E. Parker, Brian G. Feagan. The Next Wave of Biological Agents for the Treatment of IBDInflammatory Bowel Diseases 2016; 22(7): 1737 doi: 10.1097/MIB.0000000000000808
74
Kun Lv, Wei Xu, Cuini Wang, Toshiro Niki, Mitsuomi Hirashima, Sidong Xiong. Galectin-9 administration ameliorates CVB3 induced myocarditis by promoting the proliferation of regulatory T cells and alternatively activated Th2 cellsClinical Immunology 2011; 140(1): 92 doi: 10.1016/j.clim.2011.03.017
75
Nobuhiko Hayakawa, Masatsugu Noguchi, Sen Takeshita, Agung Eviryanti, Yukie Seki, Hikaru Nishio, Ryohei Yokoyama, Misato Noguchi, Manami Shuto, Yoichiro Shima, Kanna Kuribayashi, Shunsuke Kageyama, Hiroyuki Eda, Manabu Suzuki, Tomohisa Hatta, Shun-ichiro Iemura, Tohru Natsume, Itsuya Tanabe, Ryusuke Nakagawa, Makoto Shiozaki, Kuniya Sakurai, Masataka Shoji, Ayatoshi Andou, Takashi Yamamoto. Structure–activity relationship study, target identification, and pharmacological characterization of a small molecular IL-12/23 inhibitor, APY0201Bioorganic & Medicinal Chemistry 2014; 22(11): 3021 doi: 10.1016/j.bmc.2014.03.036
76
Sarah C Davies, Tran M Nguyen, Claire E Parker, Reena Khanna, Vipul Jairath, John K MacDonald. Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's diseaseCochrane Database of Systematic Reviews 2017;  doi: 10.1002/14651858.CD012804
77
Imke Atreya, Markus Kindermann, Stefan Wirtz. Innate lymphoid cells in intestinal cancer developmentSeminars in Immunology 2019; 41: 101267 doi: 10.1016/j.smim.2019.02.001
78
Kimberly A. Harris, Sara Horst, Akash Gadani, Anne Nohl, Kim Annis, Caroline Duley, Dawn Beaulieu, Leyla Ghazi, David A. Schwartz. Patients with Refractory Crohnʼs Disease Successfully Treated with UstekinumabInflammatory Bowel Diseases 2016; 22(2): 397 doi: 10.1097/MIB.0000000000000624
79
R. Queiro, D. Ginard. Ustekinumab en la artritis psoriásica y la enfermedad de CrohnActas Dermo-Sifiliográficas 2012; 103: 65 doi: 10.1016/S0001-7310(12)70011-X
80
Fernando Magro, Rosa Coelho, Armando Peixoto. Can We Extrapolate Data from One Immune-Mediated Inflammatory Disease to Another One?Current Medicinal Chemistry 2019; 26(2): 248 doi: 10.2174/0929867325666181101114937
81
Ishfaq Ahmed, Badal Roy, Parthasarathy Chandrakesan, Anand Venugopal, Lijun Xia, Roy Jensen, Shrikant Anant, Shahid Umar. Evidence of functional cross talk between the Notch and NF-κB pathways in nonneoplastic hyperproliferating colonic epitheliumAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2013; 304(4): G356 doi: 10.1152/ajpgi.00372.2012
82
Yunpeng Hua, Yi Yang, Shaoli Sun, Stephen Iwanowycz, Caroline Westwater, Boris Reizis, Zihai Li, Bei Liu. Gut homeostasis and regulatory T cell induction depend on molecular chaperone gp96 in CD11c+ cellsScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-02415-7